These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 15802267)

  • 21. MAIT cell-MR1 reactivity is highly conserved across multiple divergent species.
    Edmans MD; Connelley TK; Morgan S; Pediongco TJ; Jayaraman S; Juno JA; Meehan BS; Dewar PM; Maze EA; Roos EO; Paudyal B; Mak JYW; Liu L; Fairlie DP; Wang H; Corbett AJ; McCluskey J; Benedictus L; Tchilian E; Klenerman P; Eckle SBG
    J Biol Chem; 2024 Jun; 300(6):107338. PubMed ID: 38705391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell activation by transitory neo-antigens derived from distinct microbial pathways.
    Corbett AJ; Eckle SB; Birkinshaw RW; Liu L; Patel O; Mahony J; Chen Z; Reantragoon R; Meehan B; Cao H; Williamson NA; Strugnell RA; Van Sinderen D; Mak JY; Fairlie DP; Kjer-Nielsen L; Rossjohn J; McCluskey J
    Nature; 2014 May; 509(7500):361-5. PubMed ID: 24695216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
    Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
    J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1.
    Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J
    Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virus-Mediated Suppression of the Antigen Presentation Molecule MR1.
    McSharry BP; Samer C; McWilliam HEG; Ashley CL; Yee MB; Steain M; Liu L; Fairlie DP; Kinchington PR; McCluskey J; Abendroth A; Villadangos JA; Rossjohn J; Slobedman B
    Cell Rep; 2020 Mar; 30(9):2948-2962.e4. PubMed ID: 32130899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells.
    Laugel B; Lloyd A; Meermeier EW; Crowther MD; Connor TR; Dolton G; Miles JJ; Burrows SR; Gold MC; Lewinsohn DM; Sewell AK
    J Immunol; 2016 Aug; 197(3):971-82. PubMed ID: 27307560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MAIT cells and MR1-antigen recognition.
    Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells.
    Reantragoon R; Corbett AJ; Sakala IG; Gherardin NA; Furness JB; Chen Z; Eckle SB; Uldrich AP; Birkinshaw RW; Patel O; Kostenko L; Meehan B; Kedzierska K; Liu L; Fairlie DP; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J; Kjer-Nielsen L
    J Exp Med; 2013 Oct; 210(11):2305-20. PubMed ID: 24101382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
    Mondot S; Boudinot P; Lantz O
    Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-dependent downregulation of MR1 cell surface expression.
    Salio M; Awad W; Veerapen N; Gonzalez-Lopez C; Kulicke C; Waithe D; Martens AWJ; Lewinsohn DM; Hobrath JV; Cox LR; Rossjohn J; Besra GS; Cerundolo V
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10465-10475. PubMed ID: 32341160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of MR1 by human cytomegalovirus inhibits MAIT cell activation.
    Ashley CL; McSharry BP; McWilliam HEG; Stanton RJ; Fielding CA; Mathias RA; Fairlie DP; McCluskey J; Villadangos JA; Rossjohn J; Abendroth A; Slobedman B
    Front Immunol; 2023; 14():1107497. PubMed ID: 36845106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
    Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
    Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
    Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
    Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservation of mucosal associated invariant T (MAIT) cells and the MR1 restriction element in ruminants, and abundance of MAIT cells in spleen.
    Goldfinch N; Reinink P; Connelley T; Koets A; Morrison I; Van Rhijn I
    Vet Res; 2010; 41(5):62. PubMed ID: 20507818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of MR1 ligand glyco-analogues on mucosal-associated invariant T (MAIT) cell activation.
    Braganza CD; Shibata K; Fujiwara A; Motozono C; Sonoda KH; Yamasaki S; Stocker BL; Timmer MSM
    Org Biomol Chem; 2019 Oct; 17(40):8992-9000. PubMed ID: 31497838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viral Impacts on MR1 Antigen Presentation to MAIT Cells.
    Samer C; Traves R; Purohit SK; Abendroth A; McWilliam HEG; Slobedman B
    Crit Rev Immunol; 2021; 41(5):49-67. PubMed ID: 35381139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stepwise development of MAIT cells in mouse and human.
    Martin E; Treiner E; Duban L; Guerri L; Laude H; Toly C; Premel V; Devys A; Moura IC; Tilloy F; Cherif S; Vera G; Latour S; Soudais C; Lantz O
    PLoS Biol; 2009 Mar; 7(3):e54. PubMed ID: 19278296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR1 presentation of vitamin B-based metabolite ligands.
    McWilliam HE; Birkinshaw RW; Villadangos JA; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2015 Jun; 34():28-34. PubMed ID: 25603223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and trafficking of MR1.
    Lamichhane R; Ussher JE
    Immunology; 2017 Jul; 151(3):270-279. PubMed ID: 28419492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response.
    Kawachi I; Maldonado J; Strader C; Gilfillan S
    J Immunol; 2006 Feb; 176(3):1618-27. PubMed ID: 16424191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.